BiondVax Pharmaceuticals Ltd. Sponsored ADR Forecast, price target & analysts
$1.86
6.06%
Nasdaq, Sep 24, 04:07 pm EDT.
Closed.
BiondVax Pharmaceuticals Ltd. Sponsored ADR Target price 2026 - Analyst rating & recommendation
Powered by
BiondVax Pharmaceuticals Ltd. Sponsored ADR Classifications & Recommendation
Buy
86%
Hold
14%
BiondVax Pharmaceuticals Ltd. Sponsored ADR Price Target
| Target Price | $714.00 |
| Price | $1.86 |
| Potential |
38,287.10%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target BiondVax Pharmaceuticals Ltd. Sponsored ADR 2027 .
The average BiondVax Pharmaceuticals Ltd. Sponsored ADR target price is $714.00.
This is
38,287.10%
register free of charge
$735.00
39,416.13%
register free of charge
$707.00
37,910.75%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend BiondVax Pharmaceuticals Ltd. Sponsored ADR to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BiondVax Pharmaceuticals Ltd. Sponsored ADR stock has an average upside potential 2027 of
38,287.10%
register free of charge
|
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
